James G. Moe Moe, MD, PhD

Dr. Moe has over 29 years of industrial experience having held senior management positions in product development working on international teams in both early and late-stage diagnostic, biotechnology and biopharmaceutical companies including Gene-Trak/Amoco Technology Group/Vysis, bioMerieux, and Mosaic Technologies. He received his Ph.D. degree in molecular biology and biochemistry with a focus on molecular biophysics from Wesleyan University, did his postdoctoral studies at Vanderbilt University in the Center for Molecular Toxicology where he was jointly appointed in the Biochemistry Department in the Medical School, and the Chemistry Department in the College of Arts and Sciences, and has an MBA degree with a concentration in entrepreneurial studies from Boston University.